. Author manuscript; available in PMC: 2021 Oct 22.

Published in final edited form as: Int J Toxicol. 2021 Jul 19;40(5):442–452. doi: 10.1177/10915818211031239

Table 3:

Hematology results

Group	Treatment	Gender	HGB (g/dL)		HCT (%)		ABNEUT (K/μL)		ABBAS (K/μL)
Group	Treatment	Gender	Day 31	Day 43	Day 31	Day 43	Day 31	Day 43	Day 31	Day 43
1	0.9% Saline (control)	M	16.06	15.85	48.29	47.09	2.127	2.156	0.070	0.031
2	0.5 mg CPG 7909	M	16.00	16.68	49.05	49.54	1.527	2.221	0.199^*	0.039
3	AV7909 Lot 1	M	15.13^*	16.13	46.23	47.48	4.307^*	2.539	0.160^*	0.042
4	AV7909 Lot 2	M	15.09^*	15.61	46.36	46.67	4.573^*	2.550	0.184^*	0.041
1	0.9% Saline (control)	F	15.61	16.04	46.19	46.28	1.313	1.660	0.059	0.027
2	0.5 mg CPG 7909	F	15.49	15.63	46.09	45.19	1.100	1.379	0.153^*	0.030
3	AV7909 Lot 1	F	14.31^*	15.83	42.63^*	46.31	4.069^*	1.912	0.156^*	0.038
4	AV7909 Lot 2	F	14.37^*	15.25	43.09^*	44.29	3.667^*	1.918	0.130^*	0.034

M—male; F—female; HCT – Hematocrit; HGB – Hemoglobin; ABNEUT – Absolute neutrophil number; ABBAS - Absolute basophil number

— Significantly different from the control value, p < 0.05